Search

Author/Creator Scott, Daniel A

1. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study. (August 2018)

Authors:
Pichichero, Michael; Kaur, Ravinder; Scott, Daniel A; Gruber, William C; Trammel, James; Almudevar, Anthony; Center, Kimberly J
Journal:
Lancet
Issue:
Volume 2:Number 8(2018)
Page Start:
561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine. (21st December 2021)

Authors:
Walsh, Edward E; Falsey, Ann R; Scott, Daniel A; Gurtman, Alejandra; Zareba, Agnieszka M; Jansen, Kathrin U; Gruber, William C; Dormitzer, Philip R; Swanson, Kena A; Radley, David; Gomme, Emily; Cooper, David; Schmoele-Thoma, Beate
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 8(2022)
Page Start:
1357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years. (4th October 2017)

Authors:
Chilson, Erica; Atkinson, Bruce; Hall-Murray, Cassandra; Snow, Vincenza; Schmoele-Thoma, Beate; Isturiz, Raúl E; Scott, Daniel A
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S470
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. (12th October 2021)

Authors:
Peterson, James T; Zareba, Agnieszka M; Fitz-Patrick, David; Essink, Brandon J; Scott, Daniel A; Swanson, Kena A; Chelani, Dhawal; Radley, David; Cooper, David; Jansen, Kathrin U; Dormitzer, Philip R; Gruber, William C; Gurtman, Alejandra
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 12(2022)
Page Start:
2077
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine. (21st December 2021)

Authors:
Falsey, Ann R; Walsh, Edward E; Scott, Daniel A; Gurtman, Alejandra; Zareba, Agnieszka; Jansen, Kathrin U; Gruber, William C; Dormitzer, Philip R; Swanson, Kena A; Jiang, Qin; Gomme, Emily; Cooper, David; Schmoele-Thoma, Beate
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 12(2022)
Page Start:
2056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. Issue 2 (February 2021)

Authors:
Absalon, Judith; Segall, Nathan; Block, Stan L; Center, Kimberly J; Scully, Ingrid L; Giardina, Peter C; Peterson, James; Watson, Wendy J; Gruber, William C; Jansen, Kathrin U; Peng, Yahong; Munson, Samantha; Pavliakova, Danka; Scott, Daniel A; Anderson, Annaliesa S
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 2(2021)
Page Start:
263
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. (23rd December 2021)

Authors:
Essink, Brandon; Sabharwal, Charu; Cannon, Kevin; Frenck, Robert; Lal, Himal; Xu, Xia; Sundaraiyer, Vani; Peng, Yahong; Moyer, Lisa; Pride, Michael W; Scully, Ingrid L; Jansen, Kathrin U; Gruber, William C; Scott, Daniel A; Watson, Wendy
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 3(2022)
Page Start:
390
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use. (16th May 2020)

Authors:
Baxter, Roger; Aukes, Laurie; Pelton, Stephen I; Yee, Arnold; Klein, Nicola P; Gruber, William C; Scott, Daniel A; Center, Kimberly J
Journal:
Journal of the Pediatric Infectious Diseases Society
Issue:
Volume 10:Number 2(2021)
Page Start:
141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). (3rd July 2017)

Authors:
van Deursen, Anna M M; van Houten, Marlies A; Webber, Chris; Patton, Michael; Scott, Daniel A; Patterson, Scott; Sidhu, Mohinder; Drews, Wayne; Gruber, William C; Emini, Emilio A; Grobbee, Diederick E; Bonten, Marc J M; Sanders, Elisabeth A M
Journal:
Clinical infectious diseases
Issue:
Volume 65:Number 5(2017)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗